SEC Form 4 · accession 0001179110-15-014294
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
Oct 29, 2015
Accepted (ET)
Oct 30, 2015 · 10:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Oct 29, 2015 | M | 5,335 | $3.19 | A | 159,450 | D | |
| Common StockF1 | Oct 29, 2015 | S | 5,335 | $12.0097 | D | 154,115 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $3.19 | Oct 29, 2015 | M | 5,335 | D | Jun 8, 2007 | Jun 8, 2016 | Common Stock | 5,335 | 43,414 | D |
Explanation of responses
- F1Weighted average price of shares sold.
- F2The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on June 1, 2015.
- F3Exercisable as to 21,667 shares commencing on June 8, 2007, 21,667 shares commencing on June 8, 2008, and 21,666 shares commencing on June 8, 2009.